BTCY (Biotricity) Retained Earnings : $-137.42 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Biotricity Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Biotricity's retained earnings for the quarter that ended in Dec. 2024 was $-137.42 Mil.

Biotricity's quarterly retained earnings declined from Jun. 2024 ($-134.45 Mil) to Sep. 2024 ($-136.10 Mil) and declined from Sep. 2024 ($-136.10 Mil) to Dec. 2024 ($-137.42 Mil).

Biotricity's annual retained earnings declined from Mar. 2022 ($-93.04 Mil) to Mar. 2023 ($-112.57 Mil) and declined from Mar. 2023 ($-112.57 Mil) to Mar. 2024 ($-127.50 Mil).

Biotricity Retained Earnings Historical Data

The historical data trend for Biotricity's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotricity Retained Earnings Chart

Biotricity Annual Data

Trend

Aug15

Dec16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Retained Earnings

Get a 7-Day Free Trial

-46.36

-62.82

-93.04

-112.57

-127.50

Biotricity Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Retained Earnings	Get a 7-Day Free Trial															-123.10	-127.50	-134.45	-136.10	-137.42

Biotricity Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Biotricity (OTCPK:BTCY) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Biotricity Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotricity Inc (OTCPK:BTCY) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

203 Redwood Shores Parkway, Suite 600, Redwood City, CA, USA, 94065

Website

https://www.biotricity.com

Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed; Bioheart, which is a personal heart monitor; Biokit, and Biocare health.

Executives

Chester P White	director	447 BATTERY STREET, SUITE 230, SAN FRANCISCO CA 94111
Ronald W. Mcclurg	director	C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DR, EDEN PRAIRIE MN 55344
David A Rosa	director	10901 RED CIRCLE DRIVE, SUITE 150, MINNETONKA MN 55343
Stephen Salmon	director	1177 HAGEN ROAD, NAPA CA 94558
Patricia J Kennedy	director	275 SHORELINE DRIVE, SUITE 150, REDWOOD CITY CA 94065
Norman M. Betts	director	275 SHORELINE DRIVE, SUITE 150, REDWOOD CITY CA 94065
Waqaas Al-siddiq	director, 10 percent owner, officer: CEO and Chairman of the Board	C/O 275 SHORELINE DRIVE, SUITE 150, REDWOOD CITY CA 94065
John Ayanoglou	officer: Chief Financial Officer	C/O 275 SHORELINE DRIVE, SUITE 150, REDWOOD CITY CA 94065